Drug intelligence / Profile preview

atorvastatin + fluoxetine

Development stage
Phase 2
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Atorvastatin + fluoxetine is a combination of two approved small molecule drugs, each with distinct mechanisms of action. Atorvastatin is an HMG-CoA reductase inhibitor (statin) used primarily to lower cholesterol and reduce cardiovascular risk. It works by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that increases serotonin levels in the brain by inhibiting its reuptake into presynaptic cells, thereby improving mood and treating conditions such as major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder[3][4]. There are no known clinically significant interactions between atorvastatin and fluoxetine when co-administered[1][2][7].

Other names
atorvastatin + fluoxetineatorvastatin and fluoxetine
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)SERT (Sodium-dependent serotonin transporter)NTRK2 (Tropomyosin-related kinase receptor type B)

Beyond the preview

Go deeper on atorvastatin + fluoxetine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atorvastatin + fluoxetine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call